Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg

Showing results (481-490 of 633) with videos related to

Pageof 64
Sort By:
JHEP Reports : Innovation in Hepatology|March 7, 2023
High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosisFranziska Schmalz, Janett Fischer, Hamish Innes, et al.
Genome Medicine|September 3, 2011
Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohortKatherine R Smith, Vijayaprakash Suppiah, Kate O'Connor, et al.
International Journal of Molecular Sciences|August 3, 2019
Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver FibrosisTheresa Hildegard Wirtz, Petra Fischer, Christina Backhaus, et al.
Hepatology (Baltimore, Md.)|November 3, 2011
Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment responseAndrew J Muir, Fred F Poordad, John G McHutchison, et al.
European Radiology|July 26, 2022
Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progressionOsman Öcal, Christoph J Zech, Matthias P Fabritius, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 3, 2025
Soluble Urokinase Plasminogen Activator Receptor Predicts Survival and Hepatic Decompensation in Advanced Hepatocellular CarcinomaFabian Artusa, Sven Lamatsch, Minh Duc Phan, et al.
Plos One|February 12, 2014
Vitamin D levels vary during antiviral treatment but are unable to predict treatment outcome in HCV genotype 1 infected patientsGeorgios Grammatikos, Christian Lange, Simone Susser, et al.
Gastroenterology|April 7, 2009
Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humansHermann E Wasmuth, Frank Lammert, Mirko Moreno Zaldivar, et al.
Hepatology (Baltimore, Md.)|August 19, 2014
Polymorphisms in melanoma differentiation-associated gene 5 link protein function to clearance of hepatitis C virusFranziska S Hoffmann, Andreas Schmidt, Meike Dittmann Chevillotte, et al.
Plos One|November 22, 2013
Influence of the CXCL1 rs4074 A allele on alcohol induced cirrhosis and HCC in patients of European descentHans Dieter Nischalke, Cordula Berger, Philipp Lutz, et al.
Pageof 64

Showing results (481-490 of 633) with videos related to

Sort By:
Pageof 64
JHEP Reports : Innovation in Hepatology|March 7, 2023
High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosisFranziska Schmalz, Janett Fischer, Hamish Innes, et al.
Genome Medicine|September 3, 2011
Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohortKatherine R Smith, Vijayaprakash Suppiah, Kate O'Connor, et al.
International Journal of Molecular Sciences|August 3, 2019
Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver FibrosisTheresa Hildegard Wirtz, Petra Fischer, Christina Backhaus, et al.
Hepatology (Baltimore, Md.)|November 3, 2011
Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment responseAndrew J Muir, Fred F Poordad, John G McHutchison, et al.
European Radiology|July 26, 2022
Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progressionOsman Öcal, Christoph J Zech, Matthias P Fabritius, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 3, 2025
Soluble Urokinase Plasminogen Activator Receptor Predicts Survival and Hepatic Decompensation in Advanced Hepatocellular CarcinomaFabian Artusa, Sven Lamatsch, Minh Duc Phan, et al.
Plos One|February 12, 2014
Vitamin D levels vary during antiviral treatment but are unable to predict treatment outcome in HCV genotype 1 infected patientsGeorgios Grammatikos, Christian Lange, Simone Susser, et al.
Gastroenterology|April 7, 2009
Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humansHermann E Wasmuth, Frank Lammert, Mirko Moreno Zaldivar, et al.
Hepatology (Baltimore, Md.)|August 19, 2014
Polymorphisms in melanoma differentiation-associated gene 5 link protein function to clearance of hepatitis C virusFranziska S Hoffmann, Andreas Schmidt, Meike Dittmann Chevillotte, et al.
Plos One|November 22, 2013
Influence of the CXCL1 rs4074 A allele on alcohol induced cirrhosis and HCC in patients of European descentHans Dieter Nischalke, Cordula Berger, Philipp Lutz, et al.
Pageof 64